Evidence map›Paper›PMID 25003831›Full record

ArticlePloS one2014

Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.

Lauren A Penn, Meng Qian, Enhan Zhang, Elise Ng, Yongzhao Shao, Marianne Berwick, DeAnn Lazovich, David Polsky

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Age-specific melanoma risk associated with melanocytic nevi: a pooled analysis from the M-SKIP project.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cancer management and research · 2018
    Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lauren A PennThe Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York City, New York, United States of America.
Meng QianDepartment of Population Health and Environmental Medicine, New York University School of Medicine, New York City, New York, United States of America.
Enhan ZhangDepartment of Population Health and Environmental Medicine, New York University School of Medicine, New York City, New York, United States of America.
Elise NgThe Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York City, New York, United States of America.
Yongzhao ShaoDepartment of Population Health and Environmental Medicine, New York University School of Medicine, New York City, New York, United States of America.
Marianne BerwickDivision of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico Cancer Center, Albuquerque, New Mexico, United States of America.
DeAnn LazovichDivision of Epidemiology and Community Health, School of Public Health, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
David PolskyThe Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York City, New York, United States of America.
New York University · USUniversity of Minnesota · USUniversity of New Mexico · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Indoor Tanning Use, DNA Repair and Risk of MelanomaR01CA106807 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LAZOVICH, DEANN · 2004 to 2008
$2.6M
NCI NIH HHS 5R01CA106807NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA106807
6 · The paper itself

Abstract

backgroundIdentifying individuals at increased risk for melanoma could potentially improve public health through targeted surveillance and early detection. Studies have separately demonstrated significant associations between melanoma risk, melanocortin receptor (MC1R) polymorphisms, and indoor ultraviolet light (UV) exposure. Existing melanoma risk prediction models do not include these factors; therefore, we investigated their potential to improve the performance of a risk model.

methodsUsing 875 melanoma cases and 765 controls from the population-based Minnesota Skin Health Study we compared the predictive ability of a clinical melanoma risk model (Model A) to an enhanced model (Model F) using receiver operating characteristic (ROC) curves. Model A used self-reported conventional risk factors including mole phenotype categorized as "none", "few", "some" or "many" moles. Model F added MC1R genotype and measures of indoor and outdoor UV exposure to Model A. We also assessed the predictive ability of these models in subgroups stratified by mole phenotype (e.g. nevus-resistant ("none" and "few" moles) and nevus-prone ("some" and "many" moles)).

resultsModel A (the reference model) yielded an area under the ROC curve (AUC) of 0.72 (95% CI = 0.69, 0.74). Model F was improved with an AUC = 0.74 (95% CI = 0.71-0.76, p<0.01). We also observed substantial variations in the AUCs of Models A & F when examined in the nevus-prone and nevus-resistant subgroups.

conclusionsThese results demonstrate that adding genotypic information and environmental exposure data can increase the predictive ability of a clinical melanoma risk model, especially among nevus-prone individuals.

Indexed as

GenotypeModels, StatisticalSunbathingAdultAgedAllelesArea Under CurveCase-Control StudiesFemaleGene FrequencyHumansINDEL MutationMaleMelanomaMiddle AgedMinnesotaReceptor, Melanocortin, Type 1

Identifiers

PMID25003831
PMCPMC4086828
OpenAlexW2028276179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.